SCHEMBL22296106

SCHEMBL22296106

Cc1nc2c(cc1C#N)CCCC2(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 8/20 0.39
NPSR1 Q6W5P4 3/20 0.34
GAA P10253 2/20 0.34
PPARG P37231 1/20 0.34
NCOA2 Q15596 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
ALDH1A1 P00352 9/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPK1 P28482 3/20 0.34
HTT P42858 2/20 0.34
TSHR P16473 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ALOX15 P16050 2/20 0.34
PKM P14618 1/20 0.34
HIF1A Q16665 1/20 0.33
TP53 P04637 1/20 0.33
SMAD3 P84022 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17647565 0.85 SMN1; SMN2 (0.56) SMN1; SMN2KDM4ENPSR1GAAALDH1A1
SCHEMBL29818557 0.75 SMN1; SMN2 (0.51) SMN1; SMN2KDM4ENPSR1GAAALDH1A1
SCHEMBL14698246 0.75 SMN1; SMN2 (0.51) SMN1; SMN2KDM4ENPSR1GAAALDH1A1
SCHEMBL17648733 0.74 KDM4E (0.55) SMN1; SMN2KDM4ENPSR1GAAALDH1A1
SCHEMBL14698115 0.74 SMN1; SMN2 (0.36) SMN1; SMN2KDM4ENPSR1GAAALDH1A1
SCHEMBL29818371 0.74 SMN1; SMN2 (0.36) SMN1; SMN2KDM4ENPSR1GAAALDH1A1
SCHEMBL15116256 0.72 SMN1; SMN2 (0.65) SMN1; SMN2KDM4ENPSR1GAAPPARG
SCHEMBL1105461 0.71 SMN1; SMN2 (0.63) SMN1; SMN2KDM4ENPSR1GAAPPARG
SCHEMBL23782997 0.68 KDM4E (0.43) SMN1; SMN2KDM4ENPSR1GAAPPARG
SCHEMBL7913221 0.67 KDM4E (0.50) SMN1; SMN2KDM4EGAAPPARGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-B1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2020-08-05 EP disclosed